These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2450185)

  • 1. Receptor subtypes involved in the action of calcium antagonists.
    van Zwieten PA; Timmermans PB; van Heiningen PN
    J Hypertens Suppl; 1987 Dec; 5(4):S21-8. PubMed ID: 2450185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.
    van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A
    Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor subtypes involved in the action of calcium entry blockers.
    van Zwieten PA; Timmermans PB
    Ann N Y Acad Sci; 1988; 522():351-60. PubMed ID: 2454059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenoceptor stimulation and calcium movements.
    van Zwieten PA; Timmermans PB
    Blood Vessels; 1987; 24(5):271-80. PubMed ID: 2441781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium handling in vasoconstriction to stimulation of alpha 1- and alpha 2-adrenoceptors.
    Timmermans PB; Chiu AT; Thoolen MJ
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1649-57. PubMed ID: 2891423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors.
    van Zwieten PA; van Meel JC; Timmermans PB
    Hypertension; 1983; 5(4 Pt 2):II8-17. PubMed ID: 6134673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction between calcium inhibitors and vascular alpha-adrenergic receptors].
    van Zwieten PA; Timmermans PB
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():7-13. PubMed ID: 3004370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.
    van Zwieten PA; van Meel JC; Timmermans PB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S273-9. PubMed ID: 6184552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium dependency of vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors.
    van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; de Jonge A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S113-20. PubMed ID: 2414571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between calcium antagonists and vascular postsynaptic alpha-receptors].
    van Meel JC; Timmermans PB; van Zwieten PA
    J Pharmacol; 1982; 13(3):367-79. PubMed ID: 6290792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular aspects of calcium antagonists.
    Van Zwieten PA; Van Meel JC; Timmermans PB
    Pharm Weekbl Sci; 1981 Dec; 3(6):237-47. PubMed ID: 6120500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsynaptic alpha adrenoceptors on vascular smooth muscle.
    Matthews WD; Jim KF; Hieble JP; DeMarinis RM
    Fed Proc; 1984 Nov; 43(14):2923-8. PubMed ID: 6092150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem.
    Schulte KL; Laber E; Meyer-Sabellek WA; Distler A; Gotzen R
    J Hypertens Suppl; 1985 Dec; 3(3):S239-41. PubMed ID: 2856818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of calcium-entry blockade on vasoconstrictor responses in feline mesenteric vascular bed.
    Lippton HL; Armstead WM; Hyman AL; Kadowitz PJ
    Circ Res; 1987 Oct; 61(4):570-80. PubMed ID: 2443268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of calcium antagonists: implications for hypertension and other risk factors for coronary heart disease.
    van Zwieten PA
    Am J Cardiol; 1989 Nov; 64(17):117I-121I. PubMed ID: 2554709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANG II- and TxA(2)-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways.
    Bauer J; Dau C; Cavarape A; Schaefer F; Ehmke H; Parekh N
    Am J Physiol; 1999 Jul; 277(1):H1-7. PubMed ID: 10409174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses.
    Van Meel JC; Timmermans PB; Van Zwieten PA
    Eur J Pharmacol; 1983 Aug; 92(1-2):27-34. PubMed ID: 6313390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and peripheral alpha-adrenoceptors.
    van Zwieten PA; van Meel JC; de Jonge A; Wilffert B; Timmermans PB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S19-24. PubMed ID: 6175838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
    Nichols AJ; Gellai M; Ruffolo RR
    Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells.
    Fuller AJ; Hauschild BC; Gonzalez-Villalobos R; Awayda MS; Imig JD; Inscho EW; Navar LG
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F760-7. PubMed ID: 15942047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.